Proton therapy is one of the most precise and powerful forms of radiotherapy today. It minimizes damage to healthy tissues, potentially resulting in fewer side effects than conventional radiation therapy.¹ With fewer post-treatment side effects, cancer patients can more likely live a healthy life again after proton therapy treatment.^2​

As the most versatile proton therapy system on the market today, ProteusONE provides administration and staff with more flexibility to qualify patients for proton therapy and have a positive impact on their lives. In the United States, Corewell Health (formerly Beaumont) Hospital Royal Oak, one of the proton therapy pioneers and ProteusONE early adopters, earned “high performing” recognition in the cancer field in the U.S. News & World Report 2023-2024 Best Hospitals ranking.³ The University of Texas MD Anderson Cancer Center, which also offers proton therapy treatment, is ranked as the number one cancer hospital​ in the United States.

IBA's ProteusONE proton therapy system was created for the users with the users. With its patient-centric design, ProteusONE eases your workflow, facilitates the adoption of proton therapy by institutions, and ensures the ability to treat a wide variety of patients, including complex indications.​

​Patient satisfaction and positive experiences are crucial elements for successful treatment outcomes but also for improved profitability of medical institutions.^4,5​

With its appealing Philips Ambient Experience solution, ProteusONE creates a more relaxing environment and a more comfortable and soothing experience for patients and staff, helping to improve overall treatment delivery and experience.​

​According to a study conducted in the United States, new healthcare workers entering the field are more motivated by patient care and rapid advancements in technology5, such as the increasing adoption of proton therapy.​

​Early adoption of the ProteusONE proton therapy system can give a competitive advantage and boost talent attraction and retention. Through its innovative approach to cancer therapy, it provides possibilities for healthcare workers' growth and development, supporting increased motivation, engagement, and satisfaction. ​

​Through its easy everyday use, efficient workflow design, and 360-degree accessibility around the treatment table, ProteusONE’s versatility aims to make procedures more fluid and less stressful for healthcare staff and to help improve their own day-to-day treatment experience.​

​Moreover, IBA has designed a Proteus user curriculum that provides comprehensive training on the Proteus system and additional access to our unique platform, Campus, to stay up to date with the latest clinical advancements in proton therapy.​

​ProteusONE provides an innovative, efficient and less stressful practical experience for caregivers, attracting and retaining valued staff.​

References​

1. ​Baumann BC et al. Comparative Effectiveness of Proton vs Photon Therapy as Part of Concurrent Chemoradiotherapy for Locally Advanced Cancer. JAMA Oncol. 2020;6(2):237-246.​
2. Verma V et al. Quality of Life and Patient-Reported Outcomes Following Proton Radiation Therapy: A Systematic Review. J Natl Cancer Inst. 2018 Apr 1;110(4).U.S News 2023-2024 Best Hospitals Ranking, Accessed: October 2023, Available at: https://health.usnews.com/best-hospitals​
3. Gupta D et al. Patient satisfaction with service quality as a predictor of survival outcomes in breast cancer. Support Care Cancer 22, 129–134 (2014).​
4. Deloitte, The value of patient experience, Accessed: October 2023, Available at: https://www2.deloitte.com/us/en/pages/life-sciences-and-health-care/articles/hospitals-patient-experience.html​
5. Skubish S et al. Exploring opportunities & pathways for advanced practice radiation therapy roles in the United States. Tech Innov Patient Support Radiat Oncol. 2021;17:59-62.​